This is a non-core endpoint: only basic statistics are computed.
Mucinous and mucinous cystic tumor
C3_OVARY_MUCINO
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditionsNone |
293218 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
170 |
4. Check minimum number of eventsNone |
170 |
5. Include endpointsNone |
170 |
6. Filter based on genotype QC (FinnGen only) |
168 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor
based on the number of shared cases.
Similar with more cases:
- Mucinous and mucinous cystic tumor, including Hilmo
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, including Hilmo
- malignant neoplasm of female genital organs
- Solid cancers, helper endpoint
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 168 | 168 | - |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | - |
| Median age at first event (years) | 51.91 | 51.91 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 170
- Matched controls
- 1700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
184.8
142
*
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
120.6
101
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
63.5
120.6
71
19
JEA00
NOMESCO Finland
Appendectomy
23.4
80.6
68
47
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
78.3
69
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
30.4
73.8
53
25
LCD00
NOMESCO Finland
Hysterectomy
20.2
69.5
62
47
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
34.7
68.3
46
18
JAL30
NOMESCO Finland
Omentectomy
141.3
62.0
63
7
128
Kela drug reimbursment
Cancers of female genital organs
+∞
58.8
53
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
45.9
42
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
16.1
37.7
35
27
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
35.7
33
*
A04AA01
ATC
ondansetron; systemic, rectal
36.8
31.6
40
14
WX302
NOMESCO Finland
Thoracal epidural anesthesy
35.6
30.6
39
14
H02AB02
ATC
dexamethasone; systemic
42.5
30.2
37
11
B01AB10
ATC
tinzaparin; parenteral
7.4
25.7
44
77
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
24.6
23
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.4
23.8
64
171
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.5
23.7
39
65
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
23.5
22
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
72.7
22.5
25
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.4
22.3
57
145
121
Kela drug reimbursment
Severe hypofunction of sexual glands
28.8
21.7
29
12
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
21.3
20
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
21.3
20
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
5.3
21.0
53
133
L03AA13
ATC
pegfilgrastim; parenteral
+∞
20.2
19
*
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
26.3
18.4
25
11
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
25.1
17.4
24
11
Z31.5
ICD-10 Finland
Genetic counselling
8.3
17.0
24
33
A04AA02
ATC
granisetron; systemic, transdermal
+∞
17.0
16
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.9
16.9
98
444
B01AB05
ATC
enoxaparin; parenteral
3.8
16.3
82
336
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
7.9
15.7
23
33
JN4AD
NOMESCO Finland
Body CT examination
7.7
15.3
23
34
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
14.8
14
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.7
14.4
30
62
JN4BD
NOMESCO Finland
Extensive body CT
11.2
13.8
26
27
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
13.7
13
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
13.7
13
*
130
Kela drug reimbursment
Malignant tumour
+∞
13.7
13
*
WX402
NOMESCO Finland
General anaesthesia
3.6
12.3
51
180
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
13.2
11.7
20
17
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.6
11
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
11.6
11
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
11.6
11
*
L03AA02
ATC
filgrastim; parenteral
+∞
11.6
11
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
116.9
10.5
11
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
10.5
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
10.5
10
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
10.5
10
*
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
15.9
10.2
16
11
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
32.1
9.5
12
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
105.7
9.5
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.5
9
*
C567, ,
ICD-10 Finland
+∞
9.5
9
*
Z51.5
ICD-10 Finland
Palliative care
10.4
9.0
17
18
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
94.6
8.5
9
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
8.4
8
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.9
8.0
13
10
TPX10
NOMESCO Finland
Implantation of vascular injection port
19.5
7.7
11
6
R18
ICD-10 Finland
Ascites
19.5
7.7
11
6
X77
ICPC
Malignant neopl genital female other
+∞
7.3
7
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
23.6
6.7
9
*
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
18.9
6.3
9
5
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
A04AA03
ATC
tropisetron; systemic
+∞
6.3
6
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
13.2
6.2
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
61
69
13.23
52.77
2.2
1.4
15.07
2.44
ug/l
1.27
50
54
10
5
21.11
7.22
1.1
1.8
—
—
—
0
0
30
117
2.90
5.85
11.5
5.2
0.79
1.63
mmol/l
0.63
24
96
88
584
2.05
5.02
2.4
2.1
—
—
—
0
0
47
276
1.97
3.58
1.8
1.8
—
—
—
0
0
6
9
6.86
2.89
1.2
1.0
—
—
—
0
0
80
588
1.68
2.79
7.4
3.9
1.20
1.23
mmol/l
1.45
71
522
7
15
4.82
2.62
1.1
1.0
—
—
—
0
0
86
653
1.64
2.59
7.9
4.3
1.20
1.23
mmol/l
1.62
72
557
6
11
5.61
2.56
1.2
1.0
—
—
—
0
0
151
1611
0.44
2.56
23.1
16.2
39.15
39.68
%
0.63
137
1524
132
1465
0.56
2.41
3.9
4.5
5.81
5.84
mmol/l
0.12
114
1349
76
567
1.62
2.41
4.4
3.0
35.00
36.54
g/l
1.29
71
519
5
8
6.40
2.39
1.2
1.0
—
—
—
0
0
137
1502
0.55
2.31
4.2
5.0
2.91
2.85
mmol/l
0.32
122
1396
14
60
2.45
2.28
17.0
5.0
24.60
25.39
mmol/l
0.32
14
60
128
1426
0.59
2.21
5.9
5.4
1.82
2.68
mu/l
0.51
117
1320
145
1555
0.54
1.94
11.6
8.4
23.91
23.16
u/l
0.22
137
1494
122
1365
0.62
1.94
4.7
5.7
39.17
39.24
mmol/mol
0.04
111
1280
22
124
1.89
1.87
14.0
4.2
105.45
104.03
mmol/l
0.66
22
124
16
290
0.51
1.86
1.5
1.6
—
—
—
0
0
50
669
0.64
1.85
2.2
2.7
88.82
74.55
ug/l
0.61
45
614
135
1472
0.60
1.85
3.7
4.5
4.91
4.86
mmol/l
0.25
121
1371
5
12
4.26
1.83
2.0
1.1
—
—
—
0
0
5
12
4.26
1.83
1.2
1.8
64.80
62.58
umol/l
—
5
12
13
62
2.19
1.70
18.8
5.5
0.69
0.73
%
0.17
13
62
13
62
2.19
1.70
18.2
5.5
1.39
1.37
%
0.04
13
62
7
159
0.42
1.65
2.0
1.9
—
—
—
0
0
5
14
3.65
1.62
1.2
1.1
—
—
—
0
0
22
131
1.78
1.59
1.6
1.6
—
—
—
0
0
22
131
1.78
1.59
1.5
1.6
—
—
—
0
0
5
15
3.40
1.53
1.8
1.1
—
—
—
0
0
6
21
2.92
1.52
1.8
1.0
—
—
—
0
0
72
574
1.44
1.51
6.7
10.0
1.17
1.19
inr
0.11
24
177
91
761
1.42
1.45
7.8
3.7
6.46
6.54
mmol/l
0.20
84
686
9
172
0.50
1.39
1.9
2.1
—
—
—
0
0
129
1402
0.67
1.36
3.3
4.0
1.26
1.23
mmol/l
0.20
111
1285
0
41
0.00
1.33
0.0
1.4
—
—
—
0
0
0
41
0.00
1.33
0.0
1.4
—
—
—
0
0
0
41
0.00
1.33
0.0
1.4
—
—
—
0
0
6
24
2.55
1.31
1.8
1.1
—
—
—
0
0
136
1460
0.66
1.30
3.7
4.4
1.60
1.61
mmol/l
0.09
121
1357
98
1109
0.73
1.23
3.8
4.2
14.78
11.26
mm/h
1.24
91
1012
5
19
2.68
1.22
1.0
1.2
—
—
—
0
0
26
364
0.66
1.12
1.2
1.3
0.69
2.01
u/ml
1.33
11
107
129
1387
0.71
1.06
15.1
9.9
83.94
80.73
ml/min/173m2
0.97
104
1104
27
190
1.50
1.05
1.7
1.6
—
—
—
0
0
87
750
1.33
1.04
12.4
6.1
3.89
4.08
e9/l
0.31
65
646
7
35
2.04
1.01
1.3
1.1
—
—
—
0
0
6
27
2.27
0.94
3.2
1.8
—
—
—
0
0
6
28
2.18
0.92
1.2
1.3
—
—
—
0
0
6
28
2.18
0.92
1.2
1.3
—
—
—
0
0
82
926
0.78
0.85
2.6
3.2
—
—
—
0
0
27
200
1.42
0.83
3.9
2.7
3.21
4.72
e6/l
0.41
14
90
55
650
0.77
0.81
1.9
2.3
77.70
79.16
nmol/l
0.13
46
577
137
1445
0.73
0.80
14.0
10.7
29.17
18.03
mg/l
3.07
118
1085
6
33
1.85
0.80
1.7
1.5
0.28
2.18
ug/l
—
6
27
10
158
0.61
0.75
2.3
1.9
2.12
2.43
g/l
—
10
147
20
144
1.44
0.72
6.9
2.5
0.96
0.99
mmol/l
0.19
20
122
53
614
0.80
0.64
2.0
2.0
95.39
98.40
pmol/l
0.17
23
288
15
106
1.46
0.60
4.1
2.4
3.72
2.61
mmol/l
0.47
15
88
114
1059
1.23
0.60
7.2
4.9
78.47
76.18
u/l
0.27
103
967
148
1532
0.74
0.58
18.0
12.2
66.43
68.64
umol/l
0.97
148
1532
144
1496
0.76
0.58
18.0
12.5
3.90
3.94
mmol/l
0.81
139
1450
27
215
1.30
0.55
3.5
2.5
1.03
1.33
e6/l
0.33
14
105
9
60
1.53
0.55
1.3
2.0
0.96
1.07
%
—
9
60
76
686
1.20
0.51
7.4
3.1
9.05
10.31
umol/l
2.02
71
636
12
84
1.46
0.51
1.3
1.6
—
—
—
0
0
25
308
0.78
0.50
1.3
1.3
59.69
36.70
iu/ml
—
7
105
10
143
0.68
0.50
2.0
1.5
1.31
1.32
%
—
10
129
14
102
1.41
0.49
8.9
3.0
319.00
234.53
u/l
0.42
14
97
14
187
0.73
0.49
3.9
4.3
34.80
33.41
%
—
5
117
7
48
1.48
0.47
1.3
1.5
0.30
0.23
g/l
—
7
48
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
9
70
1.30
0.37
1.1
1.4
—
—
—
0
0
16
127
1.29
0.35
2.3
1.6
—
—
—
0
0
7
96
0.72
0.32
2.3
1.4
—
—
—
0
0
39
437
0.86
0.31
2.7
3.5
3.11
4.34
mg/mmol
0.33
21
246
48
433
1.15
0.31
3.2
2.0
51.28
58.51
u/l
0.40
43
395
23
270
0.83
0.31
1.7
1.7
1303.00
1126.21
nmol/l
0.23
11
201
47
517
0.87
0.29
3.1
3.5
19.34
92.75
ng/l
0.51
31
331
15
181
0.81
0.27
2.1
1.9
12.21
13.68
umol/l
0.28
15
169
53
571
0.90
0.24
4.7
3.7
—
—
—
0
0
119
1228
0.90
0.22
5.0
4.6
15.23
14.69
pmol/l
1.61
109
1130
28
313
0.87
0.22
1.2
1.3
4.39
12.73
u/ml
1.07
12
116
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
1.08
—
0
6
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
15
173
0.85
0.17
4.5
6.0
—
—
—
0
0
12
101
1.20
0.17
8.4
3.6
4.62
4.50
pmol/l
0.21
12
87
8
68
1.19
0.17
1.6
1.5
—
—
—
0
0
38
354
1.09
0.15
1.3
1.4
—
—
—
0
0
14
122
1.16
0.14
3.9
3.2
—
—
—
0
0
92
944
0.94
0.10
3.2
2.8
45.49
38.23
u/l
0.37
79
874
5
43
1.17
0.10
1.0
1.2
—
10.89
—
0
8
38
361
1.07
0.09
4.8
2.8
0.14
0.52
e6/l
2.20
28
261
39
371
1.07
0.09
4.0
4.0
0.00
0.00
estimate
-0.00
14
137
45
467
0.95
0.07
4.5
2.8
—
—
—
0
0
70
717
0.96
0.06
4.6
3.7
0.00
0.00
estimate
-0.00
17
147
11
100
1.11
0.05
8.4
1.2
65.93
67.64
g/l
0.57
11
91
10
91
1.11
0.04
1.1
1.6
—
—
—
0
0
12
112
1.08
0.03
1.8
2.5
66.83
68.69
ng/l
0.07
12
95
29
282
1.03
0.02
1.4
1.8
495.54
450.94
pmol/l
0.21
24
229
36
368
0.97
0.02
3.1
2.9
458.74
1120.36
ng/l
2.13
29
298
47
474
0.99
0.00
4.4
1.9
2.39
2.36
mmol/l
0.81
38
406
74
735
1.01
0.00
4.5
3.8
0.00
0.02
estimate
0.50
17
137
14
138
1.02
0.00
1.2
1.2
268.60
121.79
iu/ml
—
5
60
73
729
1.00
0.00
6.6
5.1
0.00
0.00
estimate
-0.00
16
131
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
4.70
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
0.01
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
9.90
—
0
7
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
56.29
—
0
7
0
9
0.00
-0.00
0.0
3.1
—
520.33
—
0
9
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
14.00
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_MUCINO – Mucinous and mucinous cystic tumor
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).